Cornerstone Advisory, LLC Amgen Inc Transaction History

Cornerstone Advisory, LLC

$720 Million
Q3 2024

A detailed history of Cornerstone Advisory, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cornerstone Advisory, LLC holds 2,492 shares of AMGN stock, worth $697,784. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,492

Previous 2,476 0.65%

Holding current value

$697,784

Previous $773,000 3.75%

% of portfolio

0.11%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $4,950 - $5,398	16 Added 0.65%	2,492 $802,000
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $2,102 - $2,554	8 Added 0.32%	2,476 $773,000
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $9,679 - $11,684	-36 Reduced 1.44%	2,468 $701,000
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $25,314 - $28,557	99 Added 4.12%	2,504 $721,000
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $5,903 - $7,329	27 Added 1.14%	2,405 $646,000
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $4,713 - $5,574	22 Added 0.93%	2,378 $527,000
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $6,773 - $8,256	30 Added 1.29%	2,356 $569,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $1,374 - $1,746	6 Added 0.26%	2,326 $610,000
Q1 2022 May 20, 2022	SELL	$219.27 - $242.57 $170,811 - $188,962	-779 Reduced 25.14%	2,320 $561,000
Q4 2021 Feb 23, 2022	BUY	$198.88 - $227.6 $254,964 - $291,783	1,282 Added 70.56%	3,099 $698,000
Q3 2021 Nov 16, 2021	BUY	$212.27 - $248.7 $212 - $248	1 Added 0.06%	1,817 $387,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $1,635 - $1,813	-7 Reduced 0.38%	1,816 $443,000
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $356,165 - $415,053	-1,605 Reduced 46.82%	1,823 $454,000
Q4 2020 May 11, 2021	BUY	$216.38 - $257.67 $49,334 - $58,748	228 Added 7.12%	3,428 $788,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $70,395 - $78,285	300 Added 10.34%	3,200 $813,000
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $287,615 - $352,943	1,454 Added 100.55%	2,900 $684,000
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $72,896 - $96,680	-400 Reduced 21.67%	1,446 $293,000
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $1,324 - $1,702	-7 Reduced 0.38%	1,846 $445,000
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $50,010 - $58,623	-300 Reduced 13.93%	1,853 $342,000
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $14,469 - $16,310	-80 Reduced 3.58%	2,153 $409,000
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $1,248 - $1,457	7 Added 0.31%	2,233 $435,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $1,482 - $1,671	-8 Reduced 0.36%	2,226 $462,000
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $4,151 - $4,662	25 Added 1.13%	2,234 $412,000
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $9,826 - $11,484	-58 Reduced 2.56%	2,209 $377,000
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $1,181 - $1,320	7 Added 0.31%	2,267 $394,000
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $669 - $764	-4 Reduced 0.18%	2,260 $422,000
Q2 2017 Aug 08, 2017	BUY	N/A	2,264	2,264 $390,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisory, LLC with notifications on news.

Account

Cornerstone Advisory, LLC Amgen Inc Transaction History